ask="0.5149"
ask_size="2100"
average_daily_volume="507505"
bid="0.5100"
bid_size="2500"
book_value="0.6320"
change="-0.0102"
change_from_200_day_moving_average="0.0099"
change_from_50_day_moving_average="-0.0475"
change_from_52_week_high="-0.9051"
change_From_52_week_low="0.1838"
change_in_percent="-1.9429%"
close="0.5148"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.6720"
ebitda="-18.47M"
eps_estimate_current_year="-0.7800"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.6200"
ex_dividend_date="N/A"
float_shares="29693000"
high="0.5249"
high_52_weeks="1.4199"
last_trade_date="3/14/2017"
last_trade_price="0.5148"
last_trade_size="105"
last_trade_time="4:00pm"
low="0.5100"
low_52_weeks="0.3310"
market_capitalization="15.49M"
moving_average_200_day="0.5049"
moving_average_50_day="0.5623"
name="OncoGenex Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="0.9000"
open="0.5248"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+1.9555%"
percent_change_from_50_day_moving_average="-8.4452%"
percent_change_from_52_week_high="-63.7439%"
percent_change_from_52_week_low="+55.5287%"
previous_close="0.5250"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.8307"
price_per_sales="3.1203"
revenue="5.06M"
shares_outstanding="30086000"
short_ratio="4.0600"
stock_exchange="NCM"
symbol="OGXI"
volume="78580"
weeks_range_52="0.3310 - 1.4199"
